Jason Mills

Stock Analyst at Canaccord Genuity

(1.93)
# 3,320
Out of 4,479 analysts
59
Total ratings
68.25%
Success rate
32.06%
Average return

17 Stocks

Penumbra
May 8, 2024
Maintains: Buy
Price Target: $284$272
Current: $175.99
Upside: +54.55%
TransMedics Group
May 1, 2024
Maintains: Buy
Price Target: $102$117
Current: $148.97
Upside: -21.46%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $44.52
Upside: +99.91%
Vapotherm
Apr 14, 2020
Maintains: Buy
Price Target: n/a
Current: $2.10
Upside: -
LeMaitre Vascular
Apr 14, 2020
Maintains: Hold
Price Target: n/a
Current: $81.19
Upside: -
iRhythm Technologies
Apr 13, 2020
Maintains: Buy
Price Target: n/a
Current: $98.61
Upside: -
AtriCure
Apr 13, 2020
Maintains: Buy
Price Target: n/a
Current: $22.39
Upside: -
Neuronetics
Apr 9, 2020
Maintains: Buy
Price Target: n/a
Current: $1.75
Upside: -
AngioDynamics
Apr 8, 2020
Maintains: Hold
Price Target: n/a
Current: $5.66
Upside: -
Tactile Systems Technology
Apr 7, 2020
Maintains: Buy
Price Target: n/a
Current: $11.32
Upside: -
Nevro
Apr 2, 2020
Maintains: Buy
Price Target: n/a
Current: $8.35
Upside: -
Intuitive Surgical
Apr 22, 2019
Maintains: Buy
Price Target: n/a
Current: $438.81
Upside: -
Boston Scientific
Apr 17, 2019
Maintains: Buy
Price Target: n/a
Current: $76.55
Upside: -
Merit Medical Systems
Oct 26, 2018
Maintains: Buy
Price Target: n/a
Current: $86.50
Upside: -
LivaNova
Mar 1, 2018
Maintains: Hold
Price Target: n/a
Current: $52.89
Upside: -
Globus Medical
May 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $68.05
Upside: -
Avinger
Apr 11, 2017
Downgrades: Hold
Price Target: n/a
Current: $1.79
Upside: -